Skip to content
10-K

Annual Report

NEUROPATHIX, INC.

0001607062-21-000063

← back to feed
Filed
Mar 30, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Mar 30, 2021 87.29M sh
Capex FY 2020 · Dec 31, 2019 $41.95K
Operating Cash Flow FY 2020 · Dec 31, 2019 −$1.89M
Short Term Debt FY 2020 · Dec 31, 2019 $42.09K
Cash And Equivalents FY 2020 · Dec 31, 2019 $121.46K
Cash And Equivalents FY 2020 · Dec 31, 2018 $307.13K
Current Liabilities FY 2020 · Dec 31, 2019 $1.33M
Total Liabilities FY 2020 · Dec 31, 2019 $1.92M
Current Assets FY 2020 · Dec 31, 2019 $130.86K
Total Assets FY 2020 · Dec 31, 2019 $223.38K
Sga Expense FY 2020 · Dec 31, 2019 $1.9M
Rd Expense FY 2020 · Dec 31, 2019 $554.7K
Net Income FY 2020 · Dec 31, 2019 −$3.45M
Operating Income FY 2020 · Dec 31, 2019 −$2.33M
Revenue FY 2020 · Dec 31, 2019 $126.03K
Stockholders Equity FY 2020 · Dec 31, 2018 $1.33M